A Randomized Controlled Trial of the Endeavor Resolute Zotarolimus-Eluting Stent Versus the Cypher Sirolimus-Eluting Stent for Percutaneous Coronary Intervention in a Real-World All-comer Patient Population in China.

Trial Profile

A Randomized Controlled Trial of the Endeavor Resolute Zotarolimus-Eluting Stent Versus the Cypher Sirolimus-Eluting Stent for Percutaneous Coronary Intervention in a Real-World All-comer Patient Population in China.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Oct 2017

At a glance

  • Drugs Sirolimus; Zotarolimus
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms R-China RCT
  • Sponsors Medtronic
  • Most Recent Events

    • 16 Oct 2017 Status changed from active, no longer recruiting to completed.
    • 17 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 29 Sep 2011 Actual initiation date (September 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top